The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits

Monoclonal gammopathy of renal significance (MGRS) regroups renal disorders caused by a monoclonal immunoglobulin without overt hematological malignancy. MGRS includes tubular disorders, glomerular disorders with organized deposits, and glomerular disorders with non-organized deposits, such as proli...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Kidney international 2017-03, Vol.91 (3), p.720-728
Hauptverfasser:	Vignon, Marguerite, Cohen, Camille, Faguer, Stanislas, Noel, Laure-Hélène, Guilbeau, Celine, Rabant, Marion, Higgins, Sarah, Hummel, Aurélie, Hertig, Alexandre, Francois, Hélène, Lequintrec, Moglie, Vilaine, Eve, Knebelmann, Bertrand, Pourrat, Jacques, Chauveau, Dominique, Goujon, Jean-Michel, Javaugue, Vincent, Touchard, Guy, El Karoui, Khalil, Bridoux, Frank
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Biomarkers - analysis Biopsy Cell Proliferation Diagnosis, Differential Disease Progression Female Fluorescent Antibody Technique France glomerular disease Glomerulonephritis - drug therapy Glomerulonephritis - immunology Glomerulonephritis - pathology Glomerulonephritis, IGA - drug therapy Glomerulonephritis, IGA - immunology Glomerulonephritis, IGA - pathology Heavy Chain Disease - drug therapy Heavy Chain Disease - immunology Heavy Chain Disease - pathology Human health and pathology Humans Immunoglobulin A - analysis Immunoglobulin alpha-Chains - analysis Immunoglobulin gamma-Chains - analysis Kidney - drug effects Kidney - immunology Kidney - ultrastructure Life Sciences Male Middle Aged monoclonal gammopathy of renal significance monoclonal IgA deposits Multiple Myeloma - drug therapy Multiple Myeloma - immunology Multiple Myeloma - pathology Predictive Value of Tests Prognosis Retrospective Studies Time Factors Urology and Nephrology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!